CLOSED - Clinical Trial on Primary Biliary Cholangitis (PBC) - $100

Clinical Trial on Primary Biliary Cholangitis (PBC)


Clinical research study on Primary Biliary Cholangitis (PBC). Open to men and women, ages 18-80. Must have be diagnosed with Primary Biliary Cholangitis (PBC) and feel itchy due to their PBC. Participants must not have active Hepatitis B or C. Qualified participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. All study related medications and procedures will be provided at no cost. This trial is up to 30 weeks long, requiring up to 7 visits, 1 telephone call, and no overnight stays. Open to select cities. Space is limited, register now to see if you qualify.

Space is limited, subject to availability. Criteria for qualification is subject to change at any time.

Published: 01/25/2019
City: Dallas, Miami, New York City (NYC), Sacramento
Payout: $100
Gender: Male
Age Range: 18 - 80
Facility: GlaxoSmithKline - Dallas, GlaxoSmithKline - Miami, GlaxoSmithKline - New York City (NYC), GlaxoSmithKline - Sacramento
Expires: 02/26/2020

Other focus groups: